Position in GH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$863,551,225
+$344,045,719 QoQ
Shares Held
5,755,857
+2.3% QoQ
Ownership
4.29%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#3
of 594 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $41,948,948,989 across 40 Diagnostics & Research names. GH ranks #12 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
24,276,316 | $12,171,173,789 | |
| 2 | DHR |
Danaher Corp /De/
|
41,377,076 | $7,881,505,436 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
5,152,213 | $2,712,331,011 | |
| 4 | A |
Agilent Technologies, Inc.
|
18,449,861 | $2,450,695,036 | |
| 5 | WAT |
Waters Corp /De/
|
6,415,552 | $2,406,088,622 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
10,905,053 | $2,107,074,340 | |
| 7 | NTRA |
Natera, Inc.
|
6,228,216 | $1,690,649,233 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
1,319,636 | $1,685,848,186 |
All Filings in GH
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $863,551,225 | 5,755,857 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $519,505,506 | 5,624,180 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $608,662,323 | 6,589,394 | Shares | Sole | 2026-04-30 | |
| No filing history on record for this holder in this stock. | ||||||